A US court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction treatment in the United States, Indivior said
European stocks fell in early trading on Wednesday as an escalation in the U.S.-China trade dispute looked set to bring a six-session winning streak to an end.
Britain’s Indivior (INDV.L) fell by more than 20 percent on Friday after the U.S Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film.
Britain’s Indivior posted a drop in Q1 profit, as its blockbuster treatment, Suboxone Film, lost market share in the U.S. due to stiff competition from generic versions.
ICICI Lombard sells 17.7 Lk shares or 0.84% equity at Rs 270/sh
In pact with Reliance Nippon to sell Mutual Fund products
Nextgen Vakrangee Kendras to offer mutual fund distribution on pan India basis
Plans to sell part of se Asia biz as part of strategy to exit non scalable biz
To sell Singapore & Thailand units valuing them at $ 500Mn
Singapore & Thailand biz contributes 16% to revenues & 2% to EBITDA
To turn focus to domestic market
Avendus cap-KKR emerge as frontrunner to acquire IDFC MF
Offer of Rs 3,000-4,000 Cr made by FIN services firm